Literature DB >> 15778080

Platelet factor 4: a chemokine enigma.

Arne Slungaard1.   

Abstract

Platelet factor 4 (PF4) is a platelet alpha-granule protein sequenced over 25 years ago that is a founding member of the C-X-C chemokine family, yet its physiologic function has yet to be definitively established. Initial investigations focused on possible procoagulant roles for PF4 in platelet function and plasmatic coagulation. Subsequent in vitro studies have, however, described a puzzling array of other apparently unrelated biologic functions, including inhibition of angiogenesis and hematopoiesis, promotion of neutrophil adhesion, and activation, enhancement of oxy-LDL binding to the LDL receptor and stimulation of anti-coagulant activated protein C generation by the thrombomodulin/protein C system. Preliminary studies with a just-described PF4 knockout mouse line support a role for PF4 in platelet-dependent thrombosis in vivo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15778080     DOI: 10.1016/j.biocel.2004.12.003

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  24 in total

1.  Differential gene expression in mice infected with distinct Toxoplasma strains.

Authors:  Rachel D Hill; Julia S Gouffon; Arnold M Saxton; Chunlei Su
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

2.  Identification of the platelet-derived chemokine CXCL4/PF-4 as a broad-spectrum HIV-1 inhibitor.

Authors:  David J Auerbach; Yin Lin; Huiyi Miao; Raffaello Cimbro; Michelle J Difiore; Monica E Gianolini; Lucinda Furci; Priscilla Biswas; Anthony S Fauci; Paolo Lusso
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-29       Impact factor: 11.205

3.  Platelet factor 4 is a biomarker for lymphatic-promoted disorders.

Authors:  Wanshu Ma; Hyea Jin Gil; Noelia Escobedo; Alberto Benito-Martín; Pilar Ximénez-Embún; Javier Muñoz; Héctor Peinado; Stanley G Rockson; Guillermo Oliver
Journal:  JCI Insight       Date:  2020-07-09

Review 4.  Leukocyte-rich PRP versus leukocyte-poor PRP - The role of monocyte/macrophage function in the healing cascade.

Authors:  José Fábio Lana; Stephany Cares Huber; Joseph Purita; Claudia H Tambeli; Gabriel Silva Santos; Christian Paulus; Joyce M Annichino-Bizzacchi
Journal:  J Clin Orthop Trauma       Date:  2019-05-13

5.  PF4/heparin-antibody complex induces monocyte tissue factor expression and release of tissue factor positive microparticles by activation of FcγRI.

Authors:  Raj S Kasthuri; Sam L Glover; William Jonas; Troy McEachron; Rafal Pawlinski; Gowthami M Arepally; Nigel S Key; Nigel Mackman
Journal:  Blood       Date:  2012-03-06       Impact factor: 22.113

Review 6.  Platelet secretion in inflammatory and infectious diseases.

Authors:  Bhanu K Manne; Shang Chun Xiang; Matthew T Rondina
Journal:  Platelets       Date:  2016-11-16       Impact factor: 3.862

7.  Apolipoprotein A-I and platelet factor 4 are biomarkers for infliximab response in rheumatoid arthritis.

Authors:  C Trocmé; H Marotte; A Baillet; B Pallot-Prades; J Garin; L Grange; P Miossec; J Tebib; F Berger; M J Nissen; R Juvin; F Morel; P Gaudin
Journal:  Ann Rheum Dis       Date:  2008-07-29       Impact factor: 19.103

8.  Pathophysiological mechanisms in antiphospholipid syndrome.

Authors:  Brock E Harper; Rohan Wills; Silvia S Pierangeli
Journal:  Int J Clin Rheumtol       Date:  2011-04-01

9.  Platelet factor 4 is a negative autocrine in vivo regulator of megakaryopoiesis: clinical and therapeutic implications.

Authors:  Michele P Lambert; Lubica Rauova; Matthew Bailey; Martha C Sola-Visner; M Anna Kowalska; Mortimer Poncz
Journal:  Blood       Date:  2007-05-10       Impact factor: 22.113

Review 10.  Platelet alpha-granules: basic biology and clinical correlates.

Authors:  Price Blair; Robert Flaumenhaft
Journal:  Blood Rev       Date:  2009-05-17       Impact factor: 8.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.